The FDA recently approved Dysport, an alternative to Botox. Both Dysport and Botox are similar in terms of being made from Botulinum Toxin A. For the longest time, Botox by Allergan was the only game in town, now it seems there is some competition in the market. Hopefully, this will lead to better pricing for consumers. Dysport made by French company, Ispen has been in use in Europe and Brazil for at least 10 years. In the US, it will be marketed by Arizona based Medicis under a license agreement.

The FDA continues to warn consumers that with the growing use of Botulinum toxin A products, there is a risk of the toxin spreading beyond the injection site. The box is expected to carry a label warning consumers.